FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000648021> ?p ?o ?g. }

• W2000648021 endingPage "187" @default.
• W2000648021 startingPage "179" @default.
• W2000648021 abstract "In Brief Purpose: We assess for frequency and predictive factors related to sustained intraocular pressure (IOP) elevation in eyes with neovascular age-related macular degeneration receiving intravitreal injections of ranibizumab and/or bevacizumab. Methods: A total of 328 patients with neovascular age-related macular degeneration (449 eyes) who presented to a single physician over a 6-month period were retrospectively assessed for baseline demographic/clinical information, total number of bevacizumab and/or ranibizumab injections, and sustained IOP elevation on 2 or more consecutive visits (absolute IOP >25 mmHg, increase above baseline >10 mmHg, or IOP of >21 mmHg and increase of >5 mmHg). Cox regression survival analysis and multivariate logistic regression were performed to assess the influence of intravitreal injections on experiencing sustained IOP elevation. Results: Overall, 32 eyes (7.1%) experienced sustained IOP elevation. Survival analysis showed a significant effect of the number of anti–vascular endothelial growth factor injections on sustained IOP elevation (hazard ratio, 1.085; 95% confidence interval: 1.06–1.11, P < 0.001). Also, there was an increased odds ratio (16.1, P = 0.008) of sustained IOP elevation in eyes receiving ≥29 injections compared with ≤12 injections. After controlling for the confounder (prior intravitreal steroid injection), total number of injections still showed a statistically significant association (P = 0.002). Conclusion: A greater number of intravitreal anti–vascular endothelial growth factor injections is associated with an increased risk for sustained IOP elevation in eyes with neovascular age-related macular degeneration receiving intravitreal ranbizumab and/or bevacizumab. A greater number of intravitreal ranibizumab and/or bevacizumab injections is associated with an increased risk for sustained intraocular pressure elevation in eyes with neovascular age-related macular degeneration." @default.
• W2000648021 created "2016-06-24" @default.
• W2000648021 creator A5019296720 @default.
• W2000648021 creator A5023313596 @default.
• W2000648021 creator A5026818528 @default.
• W2000648021 creator A5030940156 @default.
• W2000648021 creator A5047052383 @default.
• W2000648021 creator A5050532135 @default.
• W2000648021 creator A5079506710 @default.
• W2000648021 date "2013-01-01" @default.
• W2000648021 modified "2023-10-15" @default.
• W2000648021 title "CLINICAL PREDICTORS OF SUSTAINED INTRAOCULAR PRESSURE ELEVATION DUE TO INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY" @default.
• W2000648021 cites W1502509101 @default.
• W2000648021 cites W1802218256 @default.
• W2000648021 cites W1978908703 @default.
• W2000648021 cites W1992267606 @default.
• W2000648021 cites W1993949890 @default.
• W2000648021 cites W1997596455 @default.
• W2000648021 cites W1998126373 @default.
• W2000648021 cites W2007317284 @default.
• W2000648021 cites W2008052907 @default.
• W2000648021 cites W2031531075 @default.
• W2000648021 cites W2033944403 @default.
• W2000648021 cites W2048599732 @default.
• W2000648021 cites W2058399314 @default.
• W2000648021 cites W2058456742 @default.
• W2000648021 cites W2059265707 @default.
• W2000648021 cites W2085712747 @default.
• W2000648021 cites W2093241489 @default.
• W2000648021 cites W2107923114 @default.
• W2000648021 cites W2118288927 @default.
• W2000648021 cites W2124415048 @default.
• W2000648021 cites W2157912229 @default.
• W2000648021 cites W2325448373 @default.
• W2000648021 doi "https://doi.org/10.1097/iae.0b013e318261a6f7" @default.
• W2000648021 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22990314" @default.
• W2000648021 hasPublicationYear "2013" @default.
• W2000648021 type Work @default.
• W2000648021 sameAs 2000648021 @default.
• W2000648021 citedByCount "86" @default.
• W2000648021 countsByYear W20006480212013 @default.
• W2000648021 countsByYear W20006480212014 @default.
• W2000648021 countsByYear W20006480212015 @default.
• W2000648021 countsByYear W20006480212016 @default.
• W2000648021 countsByYear W20006480212017 @default.
• W2000648021 countsByYear W20006480212018 @default.
• W2000648021 countsByYear W20006480212019 @default.
• W2000648021 countsByYear W20006480212020 @default.
• W2000648021 countsByYear W20006480212021 @default.
• W2000648021 countsByYear W20006480212022 @default.
• W2000648021 countsByYear W20006480212023 @default.
• W2000648021 crossrefType "journal-article" @default.
• W2000648021 hasAuthorship W2000648021A5019296720 @default.
• W2000648021 hasAuthorship W2000648021A5023313596 @default.
• W2000648021 hasAuthorship W2000648021A5026818528 @default.
• W2000648021 hasAuthorship W2000648021A5030940156 @default.
• W2000648021 hasAuthorship W2000648021A5047052383 @default.
• W2000648021 hasAuthorship W2000648021A5050532135 @default.
• W2000648021 hasAuthorship W2000648021A5079506710 @default.
• W2000648021 hasConcept C118487528 @default.
• W2000648021 hasConcept C126322002 @default.
• W2000648021 hasConcept C156957248 @default.
• W2000648021 hasConcept C207103383 @default.
• W2000648021 hasConcept C2776403814 @default.
• W2000648021 hasConcept C2776694085 @default.
• W2000648021 hasConcept C2777802072 @default.
• W2000648021 hasConcept C2781092963 @default.
• W2000648021 hasConcept C2781100027 @default.
• W2000648021 hasConcept C44249647 @default.
• W2000648021 hasConcept C50440223 @default.
• W2000648021 hasConcept C71924100 @default.
• W2000648021 hasConceptScore W2000648021C118487528 @default.
• W2000648021 hasConceptScore W2000648021C126322002 @default.
• W2000648021 hasConceptScore W2000648021C156957248 @default.
• W2000648021 hasConceptScore W2000648021C207103383 @default.
• W2000648021 hasConceptScore W2000648021C2776403814 @default.
• W2000648021 hasConceptScore W2000648021C2776694085 @default.
• W2000648021 hasConceptScore W2000648021C2777802072 @default.
• W2000648021 hasConceptScore W2000648021C2781092963 @default.
• W2000648021 hasConceptScore W2000648021C2781100027 @default.
• W2000648021 hasConceptScore W2000648021C44249647 @default.
• W2000648021 hasConceptScore W2000648021C50440223 @default.
• W2000648021 hasConceptScore W2000648021C71924100 @default.
• W2000648021 hasIssue "1" @default.
• W2000648021 hasLocation W20006480211 @default.
• W2000648021 hasLocation W20006480212 @default.
• W2000648021 hasOpenAccess W2000648021 @default.
• W2000648021 hasPrimaryLocation W20006480211 @default.
• W2000648021 hasRelatedWork W1507570872 @default.
• W2000648021 hasRelatedWork W1663750035 @default.
• W2000648021 hasRelatedWork W2014260690 @default.
• W2000648021 hasRelatedWork W2024548441 @default.
• W2000648021 hasRelatedWork W2052958850 @default.
• W2000648021 hasRelatedWork W2079794035 @default.
• W2000648021 hasRelatedWork W2124415048 @default.
• W2000648021 hasRelatedWork W2343066505 @default.
• W2000648021 hasRelatedWork W2898797637 @default.
• W2000648021 hasRelatedWork W2085743381 @default.

• next